STAT3 and melanoma: Sanz-Moreno et al. demonstrated that in melanoma cells and the cancer-associated fibroblasts (CAFs), addition of pan-ROCK inhibitor H-1152 could suppress STAT3 phosphorylation through repression of JAK [27].